Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Bulbo-Spinal Atrophy, X-Linked × nilutamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4 Bulbo-Spinal Atrophy, X-Linked 1

Interventions

bicalutamide 4 pembrolizumab 1 nilutamide 1 exemestane 1 darolutamide 1 cabazitaxel 1 apalutamide 1 abemaciclib 1 Vorinostat 1 Triptorelin Pamoate 1 Tamoxifen 1 Letrozole 1 Histamine H2 Antagonists 1 Histamine Antagonists 1 Goserelin 1 Doxorubicin 1 Dasatinib 1 Cisplatin 1 CP protocol 1 Aromatase Inhibitors 1 Antiemetics 1 Anastrozole 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00918385 2014-10-29

ARS

Duke University

Phase 2 Terminated

57 enrolled 8 charts

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon ⚡